AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Sopharma AD

Earnings Release Oct 7, 2019

2543_rns_2019-10-07_496014b6-3a0e-4b01-974b-369116d0bed5.pdf

Earnings Release

Open in Viewer

Opens in native device viewer

Current report № 60/ 2019 Dated October 7, 2019

NOTIFICATION

Sopharma AD (the "Company") notifies that for September 2019 the Company recorded an increase in sales of 31% compared to the same month of 2018, incl. 5% decrease in sales for the domestic market and 66% increase in export sales.

In the first nine months of 2019 the revenues from sales of production increased by 2% compared to the same period of 2018, incl. 9% decrease in domestic sales and 10% increase in export sales.

Signatures of individuals authorized to represent the Company:

Ognian Donev

Talk to a Data Expert

Have a question? We'll get back to you promptly.